APO Research
Talk to an analyst

APO RESEARCH · REPORT

New Medical Materials and Biomaterials

New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).

Selected research

Market Analysis & Forecast

Global New Medical Materials and Biomaterials Market Analysis and Forecast 2026-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchNew Medical Materials and Biomaterials Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal New Medical Materials and Biomaterials Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal New Medical Materials and Biomaterials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal New Medical Materials and Biomaterials Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal New Medical Materials and Biomaterials Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).

In US, New Medical Materials and Biomaterials key players include STR, Avitus, Sagemax, Stratasys, Formlab, etc.

In terms of product, Bioceramics is the largest segment, with a share over 20%. And in terms of application, the largest application is Catheters, followed by Dental Products, Transplant Components, etc.

Read the full market overview

Report Includes

This report presents an overview of global market for New Medical Materials and Biomaterials, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of New Medical Materials and Biomaterials, also provides the revenue of main regions and countries. Of the upcoming market potential for New Medical Materials and Biomaterials, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the New Medical Materials and Biomaterials revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global New Medical Materials and Biomaterials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for New Medical Materials and Biomaterials revenue, projected growth trends, production technology, application and end-user industry.

New Medical Materials and Biomaterials Segment by Company

STR

Avitus

Sagemax

Stratasys

Formlab

NanoH2O (LG)

Covalent-coating

Nasseo

TriboFilm

ACS material

Palmaz Scientific

Invibio

Secant Medical

TeraPore Technologies

New Medical Materials and Biomaterials Segment by Type

Medical Polymers

Bioceramics

Medical 3D Printing Materials

Membranes

Surface Modifications

Others

New Medical Materials and Biomaterials Segment by Application

Packaging

Transplant Components

Dental Products

Catheters

Others

New Medical Materials and Biomaterials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Medical Materials and Biomaterials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of New Medical Materials and Biomaterials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Medical Materials and Biomaterials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of New Medical Materials and Biomaterials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of New Medical Materials and Biomaterials company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, New Medical Materials and Biomaterials revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global New Medical Materials and Biomaterials Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medical Polymers Major Player Table 3. Bioceramics Major Player Table 4. Medical 3D Printing Materials Major Player Table 5. Membranes Major Player Table 6. Surface Modifications Major Player Table 7. Others Major Player Table 8. Global New Medical Materials and Biomaterials Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Packaging Major Player Table 10. Transplant Components Major Player Table 11. Dental Products Major Player Table 12. Catheters Major Player Table 13. Others Major Player Table 14. New Medical Materials and Biomaterials Industry Trends Table 15. New Medical Materials and Biomaterials Industry Drivers Table 16. New Medical Materials and Biomaterials Industry Opportunities and Challenges Table 17. New Medical Materials and Biomaterials Industry Restraints Table 18. Global New Medical Materials and Biomaterials Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global New Medical Materials and Biomaterials Market Size by Region (2021-2026) & (US$ Million) Table 20. Global New Medical Materials and Biomaterials Market Share by Region (2021-2026) Table 21. Global New Medical Materials and Biomaterials Market Size by Region (2027-2032) & (US$ Million) Table 22. Global New Medical Materials and Biomaterials Market Share by Region (2027-2032) Table 23. Global New Medical Materials and Biomaterials Revenue by Players (US$ Million) & (2021-2026) Table 24. Global New Medical Materials and Biomaterials Revenue Market Share by Players (2021-2026) Table 25. Global New Medical Materials and Biomaterials Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global New Medical Materials and Biomaterials Key Players Headquarters & Area Served Table 27. Global New Medical Materials and Biomaterials Players, Product Type & Application Table 28. Global New Medical Materials and Biomaterials Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global New Medical Materials and Biomaterials by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global New Medical Materials and Biomaterials Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global New Medical Materials and Biomaterials Revenue by Type (2021-2026) & (US$ Million) Table 33. Global New Medical Materials and Biomaterials Revenue by Type (2027-2032) & (US$ Million) Table 34. Global New Medical Materials and Biomaterials Revenue Market Share by Type (2021-2026) Table 35. Global New Medical Materials and Biomaterials Revenue Market Share by Type (2027-2032) Table 36. Global New Medical Materials and Biomaterials Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global New Medical Materials and Biomaterials Revenue by Application (2021-2026) & (US$ Million) Table 38. Global New Medical Materials and Biomaterials Revenue by Application (2027-2032) & (US$ Million) Table 39. Global New Medical Materials and Biomaterials Revenue Market Share by Application (2021-2026) Table 40. Global New Medical Materials and Biomaterials Revenue Market Share by Application (2027-2032) Table 41. STR Company Information Table 42. STR Business Overview Table 43. STR New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. STR New Medical Materials and Biomaterials Product Portfolio Table 45. STR Recent Development Table 46. Avitus Company Information Table 47. Avitus Business Overview Table 48. Avitus New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Avitus New Medical Materials and Biomaterials Product Portfolio Table 50. Avitus Recent Development Table 51. Sagemax Company Information Table 52. Sagemax Business Overview Table 53. Sagemax New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Sagemax New Medical Materials and Biomaterials Product Portfolio Table 55. Sagemax Recent Development Table 56. Stratasys Company Information Table 57. Stratasys Business Overview Table 58. Stratasys New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Stratasys New Medical Materials and Biomaterials Product Portfolio Table 60. Stratasys Recent Development Table 61. Formlab Company Information Table 62. Formlab Business Overview Table 63. Formlab New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Formlab New Medical Materials and Biomaterials Product Portfolio Table 65. Formlab Recent Development Table 66. NanoH2O (LG) Company Information Table 67. NanoH2O (LG) Business Overview Table 68. NanoH2O (LG) New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. NanoH2O (LG) New Medical Materials and Biomaterials Product Portfolio Table 70. NanoH2O (LG) Recent Development Table 71. Covalent-coating Company Information Table 72. Covalent-coating Business Overview Table 73. Covalent-coating New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Covalent-coating New Medical Materials and Biomaterials Product Portfolio Table 75. Covalent-coating Recent Development Table 76. Nasseo Company Information Table 77. Nasseo Business Overview Table 78. Nasseo New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Nasseo New Medical Materials and Biomaterials Product Portfolio Table 80. Nasseo Recent Development Table 81. TriboFilm Company Information Table 82. TriboFilm Business Overview Table 83. TriboFilm New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. TriboFilm New Medical Materials and Biomaterials Product Portfolio Table 85. TriboFilm Recent Development Table 86. ACS material Company Information Table 87. ACS material Business Overview Table 88. ACS material New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. ACS material New Medical Materials and Biomaterials Product Portfolio Table 90. ACS material Recent Development Table 91. Palmaz Scientific Company Information Table 92. Palmaz Scientific Business Overview Table 93. Palmaz Scientific New Medical Materials and Biomaterials Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Palmaz Scientific New Medical Materials and Biomaterials Product Portfolio Table 95. Palmaz Scientific Recent Development Table 96. Invibio Company Information Table 97. Invibio Business Overview Table 98. Invibio New Medical Materials and Biomaterials Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Invibio New Medical Materials and Biomaterials Product Portfolio Table 100. Invibio Recent Development Table 101. Secant Medical Company Information Table 102. Secant Medical Business Overview Table 103. Secant Medical New Medical Materials and Biomaterials Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Secant Medical New Medical Materials and Biomaterials Product Portfolio Table 105. Secant Medical Recent Development Table 106. TeraPore Technologies Company Information Table 107. TeraPore Technologies Business Overview Table 108. TeraPore Technologies New Medical Materials and Biomaterials Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. TeraPore Technologies New Medical Materials and Biomaterials Product Portfolio Table 110. TeraPore Technologies Recent Development Table 111. North America New Medical Materials and Biomaterials Revenue by Type (2021-2026) & (US$ Million) Table 112. North America New Medical Materials and Biomaterials Revenue by Type (2027-2032) & (US$ Million) Table 113. North America New Medical Materials and Biomaterials Revenue by Application (2021-2026) & (US$ Million) Table 114. North America New Medical Materials and Biomaterials Revenue by Application (2027-2032) & (US$ Million) Table 115. North America New Medical Materials and Biomaterials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America New Medical Materials and Biomaterials Revenue by Country (2021-2026) & (US$ Million) Table 117. North America New Medical Materials and Biomaterials Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe New Medical Materials and Biomaterials Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe New Medical Materials and Biomaterials Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe New Medical Materials and Biomaterials Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe New Medical Materials and Biomaterials Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe New Medical Materials and Biomaterials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe New Medical Materials and Biomaterials Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe New Medical Materials and Biomaterials Revenue by Country (US$ Million) & (2027-2032) Table 125. China New Medical Materials and Biomaterials Revenue by Type (2021-2026) & (US$ Million) Table 126. China New Medical Materials and Biomaterials Revenue by Type (2027-2032) & (US$ Million) Table 127. China New Medical Materials and Biomaterials Revenue by Application (2021-2026) & (US$ Million) Table 128. China New Medical Materials and Biomaterials Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia New Medical Materials and Biomaterials Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia New Medical Materials and Biomaterials Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia New Medical Materials and Biomaterials Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia New Medical Materials and Biomaterials Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia New Medical Materials and Biomaterials Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia New Medical Materials and Biomaterials Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia New Medical Materials and Biomaterials Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA New Medical Materials and Biomaterials Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA New Medical Materials and Biomaterials Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA New Medical Materials and Biomaterials Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA New Medical Materials and Biomaterials Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA New Medical Materials and Biomaterials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA New Medical Materials and Biomaterials Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA New Medical Materials and Biomaterials Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. New Medical Materials and Biomaterials Image Figure 2. Global New Medical Materials and Biomaterials Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global New Medical Materials and Biomaterials Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medical Polymers Image Figure 5. Bioceramics Image Figure 6. Medical 3D Printing Materials Image Figure 7. Membranes Image Figure 8. Surface Modifications Image Figure 9. Others Image Figure 10. Global New Medical Materials and Biomaterials Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global New Medical Materials and Biomaterials Market Size Share 2021 VS 2025 VS 2032 Figure 12. Packaging Image Figure 13. Transplant Components Image Figure 14. Dental Products Image Figure 15. Catheters Image Figure 16. Others Image Figure 17. Global New Medical Materials and Biomaterials Market Size (US$ Million) & (2021-2032) Figure 18. Global New Medical Materials and Biomaterials Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global New Medical Materials and Biomaterials Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global New Medical Materials and Biomaterials Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global New Medical Materials and Biomaterials Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global New Medical Materials and Biomaterials Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global New Medical Materials and Biomaterials Revenue Market Share by Type (2021-2032) Figure 25. Global New Medical Materials and Biomaterials Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global New Medical Materials and Biomaterials Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global New Medical Materials and Biomaterials Revenue Market Share by Application (2021-2032) Figure 28. North America New Medical Materials and Biomaterials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America New Medical Materials and Biomaterials Revenue Share by Type (2021-2032) Figure 30. North America New Medical Materials and Biomaterials Revenue Share by Application (2021-2032) Figure 31. North America New Medical Materials and Biomaterials Revenue Share by Country (2021-2032) Figure 32. United States New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe New Medical Materials and Biomaterials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe New Medical Materials and Biomaterials Revenue Share by Type (2021-2032) Figure 37. Europe New Medical Materials and Biomaterials Revenue Share by Application (2021-2032) Figure 38. Europe New Medical Materials and Biomaterials Revenue Share by Country (2021-2032) Figure 39. Germany New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China New Medical Materials and Biomaterials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China New Medical Materials and Biomaterials Revenue Share by Type (2021-2032) Figure 49. China New Medical Materials and Biomaterials Revenue Share by Application (2021-2032) Figure 50. Asia New Medical Materials and Biomaterials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia New Medical Materials and Biomaterials Revenue Share by Type (2021-2032) Figure 52. Asia New Medical Materials and Biomaterials Revenue Share by Application (2021-2032) Figure 53. Asia New Medical Materials and Biomaterials Revenue Share by Region (2021-2032) Figure 54. Japan New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA New Medical Materials and Biomaterials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA New Medical Materials and Biomaterials Revenue Share by Type (2021-2032) Figure 62. SAMEA New Medical Materials and Biomaterials Revenue Share by Application (2021-2032) Figure 63. SAMEA New Medical Materials and Biomaterials Revenue Share by Country (2021-2032) Figure 64. Brazil New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt New Medical Materials and Biomaterials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Polymers
  • Bioceramics
  • Medical 3D Printing Materials
  • Membranes
  • Surface Modifications
  • Others
Applications
  • Packaging
  • Transplant Components
  • Dental Products
  • Catheters
  • Others
Companies covered
  • STR
  • Avitus
  • Sagemax
  • Stratasys
  • Formlab
  • NanoH2O (LG)
  • Covalent-coating
  • Nasseo
  • TriboFilm
  • ACS material
  • Palmaz Scientific
  • Invibio
  • Secant Medical
  • TeraPore Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 New Medical Materials and Biomaterials Market by Type
  3. 1.2.1 Global New Medical Materials and Biomaterials Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medical Polymers
  5. 1.2.3 Bioceramics
  6. 1.2.4 Medical 3D Printing Materials
  7. 1.2.5 Membranes
  8. 1.2.6 Surface Modifications
  9. 1.2.7 Others
  10. 1.3 New Medical Materials and Biomaterials Market by Application
  11. 1.3.1 Global New Medical Materials and Biomaterials Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Packaging
  13. 1.3.3 Transplant Components
  14. 1.3.4 Dental Products
  15. 1.3.5 Catheters
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 New Medical Materials and Biomaterials Market Dynamics
  1. 2.1 New Medical Materials and Biomaterials Industry Trends
  2. 2.2 New Medical Materials and Biomaterials Industry Drivers
  3. 2.3 New Medical Materials and Biomaterials Industry Opportunities and Challenges
  4. 2.4 New Medical Materials and Biomaterials Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global New Medical Materials and Biomaterials Market Perspective (2021-2032)
  2. 3.2 Global New Medical Materials and Biomaterials Growth Trends by Region
  3. 3.2.1 Global New Medical Materials and Biomaterials Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global New Medical Materials and Biomaterials Market Size by Region (2021-2026)
  5. 3.2.3 Global New Medical Materials and Biomaterials Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global New Medical Materials and Biomaterials Revenue by Players
  2. 4.1.1 Global New Medical Materials and Biomaterials Revenue by Players (2021-2026)
  3. 4.1.2 Global New Medical Materials and Biomaterials Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global New Medical Materials and Biomaterials Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global New Medical Materials and Biomaterials Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global New Medical Materials and Biomaterials Key Players Headquarters & Area Served
  7. 4.4 Global New Medical Materials and Biomaterials Players, Product Type & Application
  8. 4.5 Global New Medical Materials and Biomaterials Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global New Medical Materials and Biomaterials Market CR5 and HHI
  11. 4.6.3 2025 New Medical Materials and Biomaterials Tier 1, Tier 2, and Tier 3
5 New Medical Materials and Biomaterials Market Size by Type
  1. 5.1 Global New Medical Materials and Biomaterials Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global New Medical Materials and Biomaterials Revenue by Type (2021-2032)
  3. 5.3 Global New Medical Materials and Biomaterials Revenue Market Share by Type (2021-2032)
6 New Medical Materials and Biomaterials Market Size by Application
  1. 6.1 Global New Medical Materials and Biomaterials Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global New Medical Materials and Biomaterials Revenue by Application (2021-2032)
  3. 6.3 Global New Medical Materials and Biomaterials Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 STR
  2. 7.1.1 STR Company Information
  3. 7.1.2 STR Business Overview
  4. 7.1.3 STR New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  5. 7.1.4 STR New Medical Materials and Biomaterials Product Portfolio
  6. 7.1.5 STR Recent Developments
  7. 7.2 Avitus
  8. 7.2.1 Avitus Company Information
  9. 7.2.2 Avitus Business Overview
  10. 7.2.3 Avitus New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Avitus New Medical Materials and Biomaterials Product Portfolio
  12. 7.2.5 Avitus Recent Developments
  13. 7.3 Sagemax
  14. 7.3.1 Sagemax Company Information
  15. 7.3.2 Sagemax Business Overview
  16. 7.3.3 Sagemax New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sagemax New Medical Materials and Biomaterials Product Portfolio
  18. 7.3.5 Sagemax Recent Developments
  19. 7.4 Stratasys
  20. 7.4.1 Stratasys Company Information
  21. 7.4.2 Stratasys Business Overview
  22. 7.4.3 Stratasys New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Stratasys New Medical Materials and Biomaterials Product Portfolio
  24. 7.4.5 Stratasys Recent Developments
  25. 7.5 Formlab
  26. 7.5.1 Formlab Company Information
  27. 7.5.2 Formlab Business Overview
  28. 7.5.3 Formlab New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Formlab New Medical Materials and Biomaterials Product Portfolio
  30. 7.5.5 Formlab Recent Developments
  31. 7.6 NanoH2O (LG)
  32. 7.6.1 NanoH2O (LG) Company Information
  33. 7.6.2 NanoH2O (LG) Business Overview
  34. 7.6.3 NanoH2O (LG) New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NanoH2O (LG) New Medical Materials and Biomaterials Product Portfolio
  36. 7.6.5 NanoH2O (LG) Recent Developments
  37. 7.7 Covalent-coating
  38. 7.7.1 Covalent-coating Company Information
  39. 7.7.2 Covalent-coating Business Overview
  40. 7.7.3 Covalent-coating New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Covalent-coating New Medical Materials and Biomaterials Product Portfolio
  42. 7.7.5 Covalent-coating Recent Developments
  43. 7.8 Nasseo
  44. 7.8.1 Nasseo Company Information
  45. 7.8.2 Nasseo Business Overview
  46. 7.8.3 Nasseo New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nasseo New Medical Materials and Biomaterials Product Portfolio
  48. 7.8.5 Nasseo Recent Developments
  49. 7.9 TriboFilm
  50. 7.9.1 TriboFilm Company Information
  51. 7.9.2 TriboFilm Business Overview
  52. 7.9.3 TriboFilm New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  53. 7.9.4 TriboFilm New Medical Materials and Biomaterials Product Portfolio
  54. 7.9.5 TriboFilm Recent Developments
  55. 7.10 ACS material
  56. 7.10.1 ACS material Company Information
  57. 7.10.2 ACS material Business Overview
  58. 7.10.3 ACS material New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ACS material New Medical Materials and Biomaterials Product Portfolio
  60. 7.10.5 ACS material Recent Developments
  61. 7.11 Palmaz Scientific
  62. 7.11.1 Palmaz Scientific Company Information
  63. 7.11.2 Palmaz Scientific Business Overview
  64. 7.11.3 Palmaz Scientific New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Palmaz Scientific New Medical Materials and Biomaterials Product Portfolio
  66. 7.11.5 Palmaz Scientific Recent Developments
  67. 7.12 Invibio
  68. 7.12.1 Invibio Company Information
  69. 7.12.2 Invibio Business Overview
  70. 7.12.3 Invibio New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Invibio New Medical Materials and Biomaterials Product Portfolio
  72. 7.12.5 Invibio Recent Developments
  73. 7.13 Secant Medical
  74. 7.13.1 Secant Medical Company Information
  75. 7.13.2 Secant Medical Business Overview
  76. 7.13.3 Secant Medical New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Secant Medical New Medical Materials and Biomaterials Product Portfolio
  78. 7.13.5 Secant Medical Recent Developments
  79. 7.14 TeraPore Technologies
  80. 7.14.1 TeraPore Technologies Company Information
  81. 7.14.2 TeraPore Technologies Business Overview
  82. 7.14.3 TeraPore Technologies New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  83. 7.14.4 TeraPore Technologies New Medical Materials and Biomaterials Product Portfolio
  84. 7.14.5 TeraPore Technologies Recent Developments
8 North America
  1. 8.1 North America New Medical Materials and Biomaterials Revenue (2021-2032)
  2. 8.2 North America New Medical Materials and Biomaterials Revenue by Type (2021-2032)
  3. 8.2.1 North America New Medical Materials and Biomaterials Revenue by Type (2021-2026)
  4. 8.2.2 North America New Medical Materials and Biomaterials Revenue by Type (2027-2032)
  5. 8.3 North America New Medical Materials and Biomaterials Revenue Share by Type (2021-2032)
  6. 8.4 North America New Medical Materials and Biomaterials Revenue by Application (2021-2032)
  7. 8.4.1 North America New Medical Materials and Biomaterials Revenue by Application (2021-2026)
  8. 8.4.2 North America New Medical Materials and Biomaterials Revenue by Application (2027-2032)
  9. 8.5 North America New Medical Materials and Biomaterials Revenue Share by Application (2021-2032)
  10. 8.6 North America New Medical Materials and Biomaterials Revenue by Country
  11. 8.6.1 North America New Medical Materials and Biomaterials Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America New Medical Materials and Biomaterials Revenue by Country (2021-2026)
  13. 8.6.3 North America New Medical Materials and Biomaterials Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe New Medical Materials and Biomaterials Revenue (2021-2032)
  2. 9.2 Europe New Medical Materials and Biomaterials Revenue by Type (2021-2032)
  3. 9.2.1 Europe New Medical Materials and Biomaterials Revenue by Type (2021-2026)
  4. 9.2.2 Europe New Medical Materials and Biomaterials Revenue by Type (2027-2032)
  5. 9.3 Europe New Medical Materials and Biomaterials Revenue Share by Type (2021-2032)
  6. 9.4 Europe New Medical Materials and Biomaterials Revenue by Application (2021-2032)
  7. 9.4.1 Europe New Medical Materials and Biomaterials Revenue by Application (2021-2026)
  8. 9.4.2 Europe New Medical Materials and Biomaterials Revenue by Application (2027-2032)
  9. 9.5 Europe New Medical Materials and Biomaterials Revenue Share by Application (2021-2032)
  10. 9.6 Europe New Medical Materials and Biomaterials Revenue by Country
  11. 9.6.1 Europe New Medical Materials and Biomaterials Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe New Medical Materials and Biomaterials Revenue by Country (2021-2026)
  13. 9.6.3 Europe New Medical Materials and Biomaterials Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China New Medical Materials and Biomaterials Revenue (2021-2032)
  2. 10.2 China New Medical Materials and Biomaterials Revenue by Type (2021-2032)
  3. 10.2.1 China New Medical Materials and Biomaterials Revenue by Type (2021-2026)
  4. 10.2.2 China New Medical Materials and Biomaterials Revenue by Type (2027-2032)
  5. 10.3 China New Medical Materials and Biomaterials Revenue Share by Type (2021-2032)
  6. 10.4 China New Medical Materials and Biomaterials Revenue by Application (2021-2032)
  7. 10.4.1 China New Medical Materials and Biomaterials Revenue by Application (2021-2026)
  8. 10.4.2 China New Medical Materials and Biomaterials Revenue by Application (2027-2032)
  9. 10.5 China New Medical Materials and Biomaterials Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia New Medical Materials and Biomaterials Revenue (2021-2032)
  2. 11.2 Asia New Medical Materials and Biomaterials Revenue by Type (2021-2032)
  3. 11.2.1 Asia New Medical Materials and Biomaterials Revenue by Type (2021-2026)
  4. 11.2.2 Asia New Medical Materials and Biomaterials Revenue by Type (2027-2032)
  5. 11.3 Asia New Medical Materials and Biomaterials Revenue Share by Type (2021-2032)
  6. 11.4 Asia New Medical Materials and Biomaterials Revenue by Application (2021-2032)
  7. 11.4.1 Asia New Medical Materials and Biomaterials Revenue by Application (2021-2026)
  8. 11.4.2 Asia New Medical Materials and Biomaterials Revenue by Application (2027-2032)
  9. 11.5 Asia New Medical Materials and Biomaterials Revenue Share by Application (2021-2032)
  10. 11.6 Asia New Medical Materials and Biomaterials Revenue by Country
  11. 11.6.1 Asia New Medical Materials and Biomaterials Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia New Medical Materials and Biomaterials Revenue by Country (2021-2026)
  13. 11.6.3 Asia New Medical Materials and Biomaterials Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA New Medical Materials and Biomaterials Revenue (2021-2032)
  2. 12.2 SAMEA New Medical Materials and Biomaterials Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA New Medical Materials and Biomaterials Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA New Medical Materials and Biomaterials Revenue by Type (2027-2032)
  5. 12.3 SAMEA New Medical Materials and Biomaterials Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA New Medical Materials and Biomaterials Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA New Medical Materials and Biomaterials Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA New Medical Materials and Biomaterials Revenue by Application (2027-2032)
  9. 12.5 SAMEA New Medical Materials and Biomaterials Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA New Medical Materials and Biomaterials Revenue by Country
  11. 12.6.1 SAMEA New Medical Materials and Biomaterials Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA New Medical Materials and Biomaterials Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA New Medical Materials and Biomaterials Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst